FDA Inspection
Shandong Anxin Pharmaceutical Co., Ltd.Shandong Anxin Pharmaceutical Co., Ltd. – FDA Inspection, Sep 1, 2017
Record Details
This FDA Inspection record concerns Shandong Anxin Pharmaceutical Co., Ltd., with an inspection on September 1, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0bc43ad6-482b-4975-8dba-ededbb405f4a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1028356
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Shandong Anxin Pharmaceutical Co., Ltd.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2026 | Not classified | Office of Inspections and Investigations | |
| August 21, 2024 | Not classified | Office of Inspections and Investigations | |
| September 18, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 10, 2017 | Not classified | Office of Inspections and Investigations | |
| June 2, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shandong Anxin Pharmaceutical Co., Ltd.
- FDA Inspection 1332590 - 2026-07-16
- FDA Inspection 1249598 - 2024-08-21
- FDA Inspection 1157432 - 2019-09-18
- FDA Inspection 1019841 - 2017-06-10
- FDA Inspection 929464 - 2015-06-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.